We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Response to comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.
- Authors
Mahapatra, Santosh; Kumari, Swati; Mahapatra, Santosh Kumar
- Abstract
Dear Editor, We sincerely thank Varghese et al.[[1]] for their interest in our article[[2]] and we would like to put our response to their comments as follows: The authors are not denying the effectiveness of anti-VGEF in DME. However, the anti-VEGF agents are the preferred molecules over inflammatory agents in the management of DME with PDR. Thus, we can came to a conclusion that intravitreal dexamethasone can be considered as a suitable alternative to anti-VEGF as an initial therapy for DME patients except for those with PDR or at high risk for glaucoma.
- Subjects
TRIAMCINOLONE; RANIBIZUMAB; LASER photocoagulation; PEOPLE with diabetes; DEXAMETHASONE; EDEMA; INJECTIONS; RETINAL degeneration; DIABETES; DIABETIC retinopathy; DISEASE complications
- Publication
Indian Journal of Ophthalmology, 2021, Vol 69, Issue 1, p187
- ISSN
0301-4738
- Publication type
letter
- DOI
10.4103/ijo.IJO_1136_20